Centaurus Financial’s Bio-Techne TECH Stock Holding History

Centaurus Financial’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12	Closed	–	–	1885
2018 Q2	$0	Buy	+12	New	+$458	﹤0.01%	2378

Other funds holding TECH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Centaurus Financial's TECH Position: Q3 2018 in Review

Centaurus Financial sold out of Bio-Techne (TECH) in Q3 2018, closing a stake of 12 shares.

Centaurus Financial first reported a position in TECH in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 343 funds tracked by Wall St. Rank hold TECH as of Q3 2018.

Centaurus Financial reported no remaining Bio-Techne position as of Q3 2018 after selling out during the quarter.
Centaurus Financial sold 12 Bio-Techne shares in Q3 2018.
Centaurus Financial first reported a position in Bio-Techne in Q2 2018 and held it in 1 quarter.
Centaurus Financial's Bio-Techne position peaked at $0 in Q2 2018.
343 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.